drug discovery

23andM3 executive ring the Nasdaq opening bell on the day the company goes public

23andMe betting big on genomic service, therapeutics business

The company is expanding its core consumer genetic testing into a new business line called its genomic health service.

Heather Landi Oct 25, 2022 8:02am

Abstract of health data sources

Zephyr AI lands $18.5M seed round for data-driven drug discovery

Mar 30, 2022 11:33am